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1. Introduction 
Studies of the reversible inhibition of a-chymo- 
trypsin (CT) by n-alkylboronic acids have supplied 
important Information on the topography of the 
enzyme's active centre [1, 2]. The hydrocarbon 
moiety of these bifunctional inhibitors interacts 
with the hydrophobic region of the CT active centre, 
whereas the borate grouping forms a complex with 
its catalytic functional groups. The following facts 
point to participation of the catalytically active 
histidine-57 residue in the complex formation: (1) 
both HaB03 [3] as well as the alkylboronic acids 
[1,2], and also phenylboronic [4] and phenyl- 
ethylboronic [5] acids are reversible, pH-dependent 
inhibitors of CT, the pK a of the protein group con- 
trolling the degree of inhibition being 6.5-7; (2) 
HaBO a competes with Cu 2+ ions for binding by the 
CT active centre [6] ; also it has been unequivocally 
demonstrated that Cu 2÷ ions interact with the active- 
site imidazole [7, 8] ; (3) HaBO3 reversibly inhibits 
alkylation of the catalytically active imidazole by 
1,4-dibromo-2-phenylacetoin [9, 10]. In the light 
of present knowledge of borate complex chemistry 
(see e.g. [11 ]) and of the structure and mode of 
action of the CT active centre, these facts have led 
to the proposal that the OH group of the serine-195 
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residue also participates in the enzyme-borate com- 
plex, forming an ester bond (scheme 1) [12]. Such 
an inhibition mechanism has been also discussed 
by other investigators [4, 5 ]. 
It was of interest to elucidate the inhibiting capa- 
city of another series of bifunctional reversible CT 
inhibitors, namely phenylalkylboronic acids, which 
are closer analogues than the alkylboronic acids of 
the specific substrates of the enzyme. We have 
studied the relation between structure and inhibiting 
capacity of phenylalkylboronic a ds, RB(OH)2, 
where R = C6Hs(CH2)n- with n varying from 0 to 4*. 
In the quantitative treatment of the results it must 
be borne in mind that, besides the hydrophobic 
interaction with the enzyme, the substituent R may 
also contribute to the over-all action of these bi- 
functional inhibitors by the influence it can exert 
on the "complexing" properties of the borate group 
( in other words account must be taken of the R 
• substituent's steric and inductive ffects). To this 
end we investigated the complexing of substituted 
boronic acids with salicylamide. Boronic acid-sali- 
cylamide complexing was first studied by Tanner 
* While this paper was in preparation, phenylboronic [4] 
and phenylethylboronic [5] acids were found to be strong 
competitive inhibitors of CT. 
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Scheme 1. 
and Bruice [ 11 ]. This process, which involves a low- 
molecular ligand (see scheme 2), may be regarded 
as stimulating the CT-substituted boronic acids 
complexing reaction. In the model process, however, 
there is no additional hydrophobic interaction of R 
with the protein. 
2. Materials and methods 
CT was supplied by the Leningrad meat-packing 
plant [6]. The characteristics of salicylamide were 
the same as in [I 1 ]. The n-alkylboronic acids have 
been described [2]. Phenylboronic acid was a com- 
mercial preparation (Schuchardt), recrystallized fron 
water. The phenylalkylboronic a ids were synthe- 
sized according to [2] : phenylethylboronic acid, 
m.p. 83-84°;  phenylpropylboronic acid, m.p. 
78-80°;  and phenylbutylboronic a id, m.p. 81-82 °. 
The purity of the phenytalkylboronic a ids was 
assessed from their elemental analyses. 
The K i inhibition constants were determined as 
described [1, 2], with the aid of a Radiometer TTT 
1 c pH-stat using N-acetyl-L-tyrosine ethyl ester as 
substrate. 
The boronic acid-salicylamide complexing reac- 
tions were followed spectrophotometrically by re- 
cording the disappearance of the salicylamide band 
at 333 nm [11 ]. The measurements were performec 
with a Hitachi Perkin-Elmer 124 instrument. 
3. Results and discussion 
The hydrocarbon grouping of the substituted 
boronic acid molecule has relatively little effect on 
the complexing of the borate group with salicyl- 
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Scheme 2. 
amide. Although the apparent association constant, 
Kapp, does show a certain dependence on the pres- 
ence and the structure of a hydrocarbon group 
(see table 1), the observed changes do not exceed 
the limits of the ordinary inductive and steric effects 
inherent in electrophilic-nucleophilic nteractions 
[13]. Quite different is the complex formation of 
the boronic acids with the CT active centre. The 
values of the inhibition constants, K i (see table 1), 
are in this case greatly dependent upon the hydro- 
phobic capacity (log P) of the R substituent in the 
inhibitor molecule, RB(OH)2. For instance, as can 
be seen from table 1, the interaction of salicylamide 
with both H3BO3 and phenylethylboronic acid is 
characterized by approximately equal values of the 
Table 1. 
Complexing of boronic acids, RB(OH)2, with a-chymotrypsin 
active centre (Ki) and with salicylamide (Kapp) 
R Ki a,b Kapp c,d 
I/mole I/mole 
HO- 10 e 33 ± 10 
Phenyl 780 140 ± 20 
Phenylethyl 10,950 28 ± 8 
Phenylpropyl 5,200 33 ± 10 
Phenylbutyl 3,300 - 
n-Butyl 40 e 15.5 ± 3.5 
n-Amyl 105 e 12.5 ± 2.5 
n-Hexyl 370 e 10.5 -+ 1.5 
b PH 8.0 (pH-stat), 25 °, 0.1 M NaCI, 10 vol.% of CH3OH. 
Accuracy of measurement of K i values is about 10%. 
c pH 8.0 (1/15 M phosphate buffer), 20 ° , 0.02 M NaC1, 
10 vol % of CH3OH. 
d Mean and standard eviation of not less than 5 measure- 
ments. 
e Taken from [1, 2]. 
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apparent association constant, Kap p. However, the 
CT active centre reversibly binds phenylethylboronic 
acid a thousand times more effectively than H3BO3. 
The increment of free energy, favouring CT- inhibitor  
binding, is equal to the free energy of transfer of the 
C6Hs (CH2)2-  group from water to an organic solvent 
(about -4 .3  kcal/mole for the system n-octanol -  
water [14] ). 
The dependence of the inhibiting capacity of phen- 
ylalkylboronic acids, C6Hs (CH2)nB(OH)2, on the 
length of the side chain (n) has a maximum at the 
compound whose aralkyl grouping is nearest in size 
to the phenylalanine derivative (n = 2) which is the 
specific substrate of the enzyme. 
If, assuming that in the acylenzyme the substrate 
is also bound to the enzyme at two other points 
(scheme 3) the bifunctional inhibitor-CT active 
centre complex (scheme 1) may be regarded as sim- 
ulating the acylenzyme*, with hydrophobic inter- 
action between the substituent and the protein 
apparently being common to both systems. In this 
connection it is of interest o analyse the relation- 
ship between the free energy of the enzyme-inhibi-  
tor binding and of the activation of acylenzyme de- 
acylation. To this end, in fig. 1 along with our 
results (Ki) we have given also data [15] on the de- 
acylation rate (k3) of C6H s (CH2)n C O.chymotryp- 
sins. It is evident hat the binding efficiency (log Ki) 
changes parallely with changes in the catalytic 
* We do not consider it necessary to regard abifunctional in- 
hibitor as a transition state analog, as was assumed in [5]. 
If the hydrophobic binding of the R grouping with the pro- 
rein favors catalytic reaction, the gain in free energy of acti- 
vation should be the same independently of whether the 
binding occurs in the ground state of the reaction (in the 
acylenzyme) and is retained in the transition state or has 
its source only at the transition state [18]. 
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Fig. 1. The effect of the substituent R hydrophobicity 
(log P) upon the binding constant (K i) in the c~-chymotryp- 
sin-RB(OH) 2 complexing reaction and upon the deacyl- 
ation rate constants of acylchymotrypsins, RCO-enz. Ex- 
perimental conditions for measuring the inhibition con- 
stants, Ki, are given in the table. The k a values are from [15]. 
The P values were taken from the data in [14]. 
efficiency (log ka), both systems exhibiting maxi- 
mum efficiency for same size of side group, n = 2. 
These data supply direct proof of the earlier ex- 
pressed suggestion that the thermodynamically 
favourable free energy of the enzyme-substrate 
binding causes a decrease in the free energy of acti- 
vation of the chemical reaction, i.e. these data con- 
firm the postulate advanced by Knowles: "Better 
binding - better catalysis!" [ 16, 17 ]. 
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